Physician profile
Michael R Smith
NPI 1043233786
$6,162.44
in general payments reported to CMS, 2019-2025
30 companies · $400 in 2025
The $400 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,874 · 2020: $154 · 2021: $107 · 2022: $77.65 · 2023: $318 · 2024: $231 · 2025: $400.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $949.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $949.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,301.89 | 2019-2025 | Watchman Flx, Cds - Mct/Cem Monitoring |
| Janssen Pharmaceuticals, INC | $193.59 | 2019-2023 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $170.46 | 2019-2023 | Lifevest |
| Medtronic Vascular, INC. | $169.14 | 2019-2020 | |
| Pfizer INC. | $142.82 | 2019-2025 | |
| Amgen INC. | $138.27 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $126.52 | 2019-2025 | |
| Cvrx, INC. | $113.31 | 2022-2025 | Barostim Neo System |
| Sanofi-Aventis U.S. LLC | $85.17 | 2019-2024 | |
| Lantheus Medical Imaging, INC. | $65.12 | 2019-2024 | |
| Irhythm Technologies, INC. | $59.03 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Daiichi Sankyo INC. | $58.87 | 2019-2025 | Injectafer |
| Medtronic, INC. | $57.24 | 2021 | |
| Abbott Laboratories | $46.87 | 2023-2024 | Thoratec Heartmate 3 Lvas Implant Kit, Amplatzer Amulet |
| Abiomed | $46.00 | 2025 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $44.25 | 2019-2023 | Evkeeza |
| Lexicon Pharmaceuticals, INC. | $40.44 | 2023 | Inpefa |
| E.R. Squibb & Sons, L.L.C. | $39.51 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $34.30 | 2019-2023 | Farxiga |
| Philips North America LLC | $32.70 | 2023-2024 | (5044) Mcot |
| Alnylam Pharmaceuticals INC. | $28.38 | 2025 | Amvuttra |
| Trevena, INC. | $24.01 | 2022 | |
| Chiesi USA, INC. | $22.27 | 2025 | Juxtapid |
| Celgene Corporation | $21.57 | 2023 | Eliquis |
| Inspire Medical Systems, INC. | $18.76 | 2025 | Inspire |
| Amarin Pharma, INC. | $17.75 | 2020 | |
| Baxter Healthcare | $17.70 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Bayer Healthcare Pharmaceuticals INC. | $16.80 | 2023 | |
| W. L. Gore & Associates, INC. | $16.19 | 2020 | |
| Glaxosmithkline, LLC. | $13.51 | 2025 | Shingrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.